These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30670495)

  • 1. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
    Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
    Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
    Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
    Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab.
    Zhang H; Yuan L; Liu L; Yan C; Cheng J; Fu Q; Tong Z; Jiang W; Zheng Y; Zhao P; Zhang G; Fang W
    BMC Cancer; 2020 May; 20(1):416. PubMed ID: 32404198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
    Vangala D; Ladigan S; Liffers ST; Noseir S; Maghnouj A; Götze TM; Verdoodt B; Klein-Scory S; Godfrey L; Zowada MK; Huerta M; Edelstein DL; de Villarreal JM; Marqués M; Kumbrink J; Jung A; Schiergens T; Werner J; Heinemann V; Stintzing S; Lindoerfer D; Mansmann U; Pohl M; Teschendorf C; Bernhardt C; Wolters H; Stern J; Usta S; Viebahn R; Admard J; Casadei N; Fröhling S; Ball CR; Siveke JT; Glimm H; Tannapfel A; Schmiegel W; Hahn SA
    Genome Med; 2021 Jul; 13(1):116. PubMed ID: 34271981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
    Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
    Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-X
    Oh Y; Jung HR; Min S; Kang J; Jang D; Shin S; Kim J; Lee SE; Sung CO; Lee WS; Lee C; Jeong EM; Cho SY
    Cancer Lett; 2021 Jan; 497():123-136. PubMed ID: 33068701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research.
    Suto H; Funakoshi Y; Nagatani Y; Imamura Y; Toyoda M; Kiyota N; Matsumoto H; Tanaka S; Takai R; Hasegawa H; Yamashita K; Matsuda T; Kakeji Y; Minami H
    J Cancer Res Ther; 2021; 17(6):1358-1369. PubMed ID: 34916366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.
    Sato K; Niida A; Masuda T; Shimizu D; Tobo T; Kuroda Y; Eguchi H; Nakagawa T; Suzuki Y; Mimori K
    Cancer Genomics Proteomics; 2019; 16(1):21-27. PubMed ID: 30587497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.
    Arena S; Corti G; Durinikova E; Montone M; Reilly NM; Russo M; Lorenzato A; Arcella P; Lazzari L; Rospo G; Pagani M; Cancelliere C; Negrino C; Isella C; Bartolini A; Cassingena A; Amatu A; Mauri G; Sartore-Bianchi A; Mittica G; Medico E; Marsoni S; Linnebacher M; Abrignani S; Siena S; Di Nicolantonio F; Bardelli A
    Clin Cancer Res; 2020 Mar; 26(6):1372-1384. PubMed ID: 31831554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph Node Metastases in Colon Cancer Are Polyclonal.
    Ulintz PJ; Greenson JK; Wu R; Fearon ER; Hardiman KM
    Clin Cancer Res; 2018 May; 24(9):2214-2224. PubMed ID: 29203589
    [No Abstract]   [Full Text] [Related]  

  • 13. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
    Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
    Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies.
    Russo M; Lamba S; Lorenzato A; Sogari A; Corti G; Rospo G; Mussolin B; Montone M; Lazzari L; Arena S; Oddo D; Linnebacher M; Sartore-Bianchi A; Pietrantonio F; Siena S; Di Nicolantonio F; Bardelli A
    Nat Commun; 2018 Jun; 9(1):2287. PubMed ID: 29895949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
    Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
    Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
    Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
    Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells.
    Dimitrov-Markov S; Perales-Patón J; Bockorny B; Dopazo A; Muñoz M; Baños N; Bonilla V; Menendez C; Duran Y; Huang L; Perea S; Muthuswamy SK; Al-Shahrour F; Lopez-Casas PP; Hidalgo M
    Mol Cancer Ther; 2020 Aug; 19(8):1751-1760. PubMed ID: 32499301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development.
    Vasseur D; Bigot L; Beshiri K; Flórez-Arango J; Facchinetti F; Hollebecque A; Tselikas L; Aldea M; Blanc-Durand F; Gazzah A; Planchard D; Lacroix L; Pata-Merci N; Nobre C; Da Silva A; Nicotra C; Ngo-Camus M; Braye F; Nikolaev SI; Michiels S; Jules-Clement G; Olaussen KA; André F; Scoazec JY; Barlesi F; Ponce S; Soria JC; Besse B; Loriot Y; Friboulet L
    Mol Cancer; 2024 Oct; 23(1):221. PubMed ID: 39363320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.